↓ Skip to main content

Dove Medical Press

Remicade® (infliximab): 20 years of contributions to science and medicine

Overview of attention for article published in Biologics: Targets & Therapy, July 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 287)
  • High Attention Score compared to outputs of the same age (93rd percentile)

Mentioned by

news
5 news outlets
twitter
1 X user

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
202 Mendeley
Title
Remicade® (infliximab): 20 years of contributions to science and medicine
Published in
Biologics: Targets & Therapy, July 2019
DOI 10.2147/btt.s207246
Pubmed ID
Authors

Richard Melsheimer, Anja Geldhof, Isabel Apaolaza, Thomas Schaible

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 202 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 202 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 22 11%
Student > Ph. D. Student 18 9%
Student > Master 18 9%
Researcher 16 8%
Student > Doctoral Student 12 6%
Other 30 15%
Unknown 86 43%
Readers by discipline Count As %
Medicine and Dentistry 30 15%
Biochemistry, Genetics and Molecular Biology 23 11%
Pharmacology, Toxicology and Pharmaceutical Science 20 10%
Immunology and Microbiology 9 4%
Agricultural and Biological Sciences 5 2%
Other 25 12%
Unknown 90 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 39. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2024.
All research outputs
#1,100,593
of 26,287,478 outputs
Outputs from Biologics: Targets & Therapy
#4
of 287 outputs
Outputs of similar age
#22,978
of 366,807 outputs
Outputs of similar age from Biologics: Targets & Therapy
#1
of 3 outputs
Altmetric has tracked 26,287,478 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 287 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,807 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them